Two Players in the Field: Hierarchical Model of Interaction between the Dopamine and Acetylcholine Signaling Systems in the Striatum
- PMID: 33401461
- PMCID: PMC7824505
- DOI: 10.3390/biomedicines9010025
Two Players in the Field: Hierarchical Model of Interaction between the Dopamine and Acetylcholine Signaling Systems in the Striatum
Abstract
Tight interactions exist between dopamine and acetylcholine signaling in the striatum. Dopaminergic neurons express muscarinic and nicotinic receptors, and cholinergic interneurons express dopamine receptors. All neurons in the striatum are pacemakers. An increase in dopamine release is activated by stopping acetylcholine release. The coordinated timing or synchrony of the direct and indirect pathways is critical for refined movements. Changes in neurotransmitter ratios are considered a prominent factor in Parkinson's disease. In general, drugs increase striatal dopamine release, and others can potentiate both dopamine and acetylcholine release. Both neurotransmitters and their receptors show diurnal variations. Recently, it was observed that reward function is modulated by the circadian system, and behavioral changes (hyperactivity and hypoactivity during the light and dark phases, respectively) are present in an animal model of Parkinson's disease. The striatum is one of the key structures responsible for increased locomotion in the active (dark) period in mice lacking M4 muscarinic receptors. Thus, we propose here a hierarchical model of the interaction between dopamine and acetylcholine signaling systems in the striatum. The basis of this model is their functional morphology. The next highest mode of interaction between these two neurotransmitter systems is their interaction at the neurotransmitter/receptor/signaling level. Furthermore, these interactions contribute to locomotor activity regulation and reward behavior, and the topmost level of interaction represents their biological rhythmicity.
Keywords: addiction; biological rhythm; dopamine receptors; locomotor activity; muscarinic receptors; striatum.
Conflict of interest statement
The author declares no conflict of interest.
Figures


Similar articles
-
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease.J Neurosci. 2016 Aug 31;36(35):9161-72. doi: 10.1523/JNEUROSCI.0873-16.2016. J Neurosci. 2016. PMID: 27581457 Free PMC article.
-
Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat.Brain Res. 2003 Oct 3;986(1-2):22-9. doi: 10.1016/s0006-8993(03)03165-2. Brain Res. 2003. PMID: 12965226
-
Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.Brain Res Bull. 2012 Dec 1;89(5-6):177-84. doi: 10.1016/j.brainresbull.2012.08.009. Epub 2012 Sep 5. Brain Res Bull. 2012. PMID: 22981453
-
Acetylcholine-dopamine balance hypothesis in the striatum: an update.Geriatr Gerontol Int. 2010 Jul;10 Suppl 1:S148-57. doi: 10.1111/j.1447-0594.2010.00588.x. Geriatr Gerontol Int. 2010. PMID: 20590830 Review.
-
Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.Neuroscientist. 2003 Feb;9(1):23-36. doi: 10.1177/1073858402239588. Neuroscientist. 2003. PMID: 12580337 Review.
Cited by
-
Muscarinic Receptors and Alzheimer's Disease: New Perspectives and Mechanisms.Curr Issues Mol Biol. 2024 Jul 2;46(7):6820-6835. doi: 10.3390/cimb46070407. Curr Issues Mol Biol. 2024. PMID: 39057049 Free PMC article. Review.
-
Dopamine and acetylcholine have distinct roles in delay- and effort-based decision-making in humans.PLoS Biol. 2024 Jul 12;22(7):e3002714. doi: 10.1371/journal.pbio.3002714. eCollection 2024 Jul. PLoS Biol. 2024. PMID: 38995982 Free PMC article.
-
Dopamine Dysregulation in Reward and Autism Spectrum Disorder.Brain Sci. 2024 Jul 22;14(7):733. doi: 10.3390/brainsci14070733. Brain Sci. 2024. PMID: 39061473 Free PMC article. Review.
-
Dopamine in Health and Disease.Biomedicines. 2021 Nov 9;9(11):1644. doi: 10.3390/biomedicines9111644. Biomedicines. 2021. PMID: 34829873 Free PMC article.
-
Differential Influence of Amyloid-β on the Kinetics of Dopamine Release in the Dorsal and Ventral Striatum of Rats.Neurotox Res. 2021 Aug;39(4):1285-1292. doi: 10.1007/s12640-021-00371-9. Epub 2021 May 15. Neurotox Res. 2021. PMID: 33991320
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources